RECENT ADVANCES
- Receptor Transporter Protein 4 (RTP4) in the hypothalamus is involved in the development of antinociceptive tolerance to Morphine
(Fujita W et al., 2022) - SLITRK1-mediated noradrenergic projection suppression in the neonatal prefrontal cortex
(Hatayama M et al., 2022) (1/2) - A revertant of Homo sapiens-specific residue in SLITRK1 alters its protein function
(Hatayama M et al., 2022) (2/2) - Slitrk2 deficiency causes hyperactivity with altered vestibular function and serotonergic dysregulation
(Katayama K et al., 2022) - Leucine-Rich Repeats and Transmembrane Domain 2 controls protein sorting in the striatal projection system and its deficiency causes disturbances in motor responses and monoamine dynamics
(Ichise M et al., 2022) - Dysregulation of erythropoiesis and altered erythroblastic NMDA receptor-mediated calcium influx in Lrfn2-deficient mice
(Maekawa R et al., 2021) - Sphingosine 1-phosphate signaling is involved in impaired blood-brain barrier function in ischemia-reperfusion injury.
(Nakagawa S et al., 2019) - Identification and characterization of novel conserved domains in metazoan Zic proteins
(Tohmonda T et al., 2018) - Zic family – Evolution, Development and Disease
(Aruga J Ed, 2018) - Link between the causative genes of holoprosencephaly: Zic2 directly regulates Tgif1 expression
(Ishiguro A et al., 2018) - Autism-like behaviours and enhanced memory formation and synaptic plasticity in Lrfn2/SALM1-deficient mice.
(Morimura N et al., 2017) - Elfn1 recruits presynaptic mGluR7 in trans and its loss results in seizures.
(Tomioka N et al., 2014) - Hepatocyte growth factor enhances the barrier function in primary cultures of rat brain microvascular endothelial cells.
(Yamada N et al., 2014) - Cilostazol attenuates ischemia-reperfusion-induced blood-brain barrier dysfunction enhanced by advanced glycation endproducts via transforming growth factor-β1 signaling.
(Takeshita T et al., 2014) - Rines E3 Ubiquitin Ligase Regulates MAO-A Levels and Emotional Responses.
(Kabayama et al., 2013) - SLITRK6 mutations cause myopia and deafness in humans and mice.
(Tekin et al., 2013)